Search Results - Weisenberg, Judith
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
LGG-38. Dose-dependent seizure control for an NF1 patient treated via MEK-inhibition for optic pathway glioma by Cantor, Evan, Meyer, Ashley, Ogle, Andrea, Shatara, Margaret, Cluster, Andrew, Abdelbaki, Mohamed S, Morris, Stephanie, Weisenberg, Judith, Brossier, Nicole M
Published 2022Text -
5
Content validation of clinician-reported items for a severity measure for CDKL5 Deficiency Disorder by Saldaris, Jacinta, Weisenberg, Judith, Pestana-Knight, Elia, Marsh, Eric D., Suter, Bernhard, Rajaraman, Rajsekar, Heidary, Gena, Olson, Heather E., Devinsky, Orrin, Price, Dana, Jacoby, Peter, Leonard, Helen, Benke, Tim A., Demarest, Scott, Downs, Jenny
Published 2021Text -
6
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder by Olson, Heather E., Daniels, Carolyn I., Haviland, Isabel, Swanson, Lindsay C., Greene, Caitlin A., Denny, Anne Marie M., Demarest, Scott T., Pestana-Knight, Elia, Zhang, Xiaoming, Moosa, Ahsan N., Fidell, Andrea, Weisenberg, Judith L., Suter, Bernhard, Fu, Cary, Neul, Jeffrey L., Percy, Alan K., Marsh, Eric D., Benke, Timothy A., Poduri, Annapurna
Published 2021Text -
7
Severity Assessment in CDKL5 Deficiency Disorder by Demarest, Scott, Pestana-Knight, Elia M., Olson, Heather E., Downs, Jenny, Marsh, Eric D., Kaufmann, Walter E., Partridge, Carol-Anne, Leonard, Helen, Gwadry-Sridhar, Femida, Frame, Katheryn Elibri, Cross, J. Helen, Chin, Richard F.M., Parikh, Sumit, Panzer, Axel, Weisenberg, Judith, Utley, Karen, Jaksha, Amanda, Amin, Sam, Khwaja, Omar, Devinsky, Orrin, Neul, Jeffery L., Percy, Alan K., Benke, Tim A.
Published 2019Text